Dr. Martens plc (DOCMF)
Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
At close: 03:42PM EDT
| Previous Close | 0.9000 |
| Open | 0.9210 |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's Range | 0.9210 - 0.9210 |
| 52 Week Range | 0.7670 - 2.2099 |
| Volume | |
| Avg. Volume | 18,263 |
| Market Cap | 894.739M |
| Beta (5Y Monthly) | -0.03 |
| PE Ratio (TTM) | 7.08 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | 0.08 (8.42%) |
| Ex-Dividend Date | Jan 04, 2024 |
| 1y Target Est | N/A |
- GlobeNewswire
Marathon Partners Calls for Strategic Review Process for Dr. Martens
Recommends that the Board hire an Advisor and Commence a Strategic Review with the Goal of Maximizing Shareholder Value Believes an Auction Process for Dr. Martens would likely Result in a Substantial Acquisition Premium for Shareholders Notes Poor Shareholder Returns since the Initial and Secondary Share Offerings of the Company NEW YORK, April 02, 2024 (GLOBE NEWSWIRE) -- Marathon Partners Equity Management, LLC, a New York-based investment firm, and its affiliated investment funds (collective
© 2024 Yahoo. All rights reserved.